Albendazole therapy for subarachnoid and ventricular cysticercosis
Óscar H. Del Brutto, Julio Sotelo
Abstract
Óscar H. Del Brutto, Julio Sotelo
Abstract
Medical or surgical therapy for subarachnoid or ventricular cysticercosis is a controversial issue. The authors report a patient with cysticercus larvae in both ventricular and subarachnoid locations, who was successfully treated with albendazole. Thus, medical therapy has a role in the treatment of these forms of neurocysticercosis.
OpenAlex reports 89 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Medical or surgical therapy for subarachnoid or ventricular cysticercosis is a controversial issue. The authors report a patient with cysticercus larvae in both ventricular and subarachnoid locations, who was successfully treated with albendazole. Thus, medical therapy has a role in the treatment of these forms of neurocysticercosis.
Key concepts: Albendazole, Neurocysticercosis, Cysticercosis, Medicine, Subarachnoid haemorrhage, Medical therapy, Cysticercus, Helminthiasis